RepliCel Life Sciences Inc. is leading a revolution in the development of products for sports medicine and aesthetics. We are a regenerative medicine company developing innovative, clinical-stage technologies for unparalleled skin rejuvenation, tendon regeneration, and hair regrowth. RepliCel is currently involved in three clinical development programs: RCT-01 for treatment of Achilles tendinosis, RCS-01 for skin rejuvenation, and RCH-01 for treatment of Androgenic Alopecia. In Asia, RCH-01 is the subject of a co-development partnership with cosmetics and skincare giant Shiseido Company, Limited. Shiseido is currently funding a clinical study for the treatment of male and female pattern baldness (androgenic alopecia) in Japan with data anticipated in late 2018. RepliCel's nearest-term commercial asset is its next-generation dermal injector, RCI-02 which represents a medical device bringing unparalleled precision and consistency to dermal injections including shallow, even dispersion of dermal fillers for fine wrinkles. RCI-02 also promises to obviate the need for local anesthetic injections due to its patented skin-numbing element embedded in the device.
View Top Employees from RepliCel Life Sciences Inc.Website | http://www.replicel.com/ |
Ticker | RP |
Revenue | $89000 |
Employees | 6 (3 on RocketReach) |
Founded | 2010 |
Address | Suite 900, 570 Granville St, Vancouver, British Columbia V6C 3P1, CA |
Phone | (604) 248-8730 |
Fax | (604) 248-8690 |
Technologies |
JavaScript,
PHP,
Twitter
+15 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Hair Rejuvenation, Business Services, Science and Engineering, Tendon Repair, Clinical Trials, Androgenetic Alopecia, Health Care, Skin Rejuvenation, Therapeutics, Tendinosis, Dermal Injector |
Web Rank | 902381 |
Keywords | Replicel, Rch-01, Shiseido Replicell, Replicel Rch-01, Repicel |
Competitors | Cynata Therapeutics, Intercytex Ltd, Longeveron Inc, Sernova Corp., jCyte, Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular RepliCel Life Sciences Inc. employee's phone or email?
The RepliCel Life Sciences Inc. annual revenue was $89000 in 2024.
3 people are employed at RepliCel Life Sciences Inc..
RepliCel Life Sciences Inc. is based in Vancouver, British Columbia.
The NAICS codes for RepliCel Life Sciences Inc. are [54171, 54, 541714, 541, 5417].
The SIC codes for RepliCel Life Sciences Inc. are [87, 873].